Login / Signup

Phase-Specific Healthcare Costs Associated With Giant Cell Arteritis in Ontario, Canada.

Mats L JunekLillian B BarraAlexander KoppTina FelfeliJodi M GatleyJessica Widdifield
Published in: The Journal of rheumatology (2024)
A diagnosis of GCA was associated with increased healthcare costs during all 3 phases of care. Given the substantial economic burden, strategies to reduce the healthcare utilization and costs associated with GCA are warranted.
Keyphrases
  • healthcare
  • giant cell
  • quality improvement
  • affordable care act
  • pain management